Literature DB >> 22158080

Hypertension in 2011: New insights--from risk factors to treatment implications.

George L Bakris1.   

Abstract

The results of several hypertension studies published in 2011 have contributed to our knowledge on the risks of and treatment for this condition, including the effects of slow-wave sleep, nocturnal dosing of medication, variability in post-stroke blood-pressure reduction, and the impacts of a low-sodium diet.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22158080     DOI： 10.1038/nrcardio.2011.202

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

1.  Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; José R Fernández
Journal:  J Am Soc Nephrol       Date:  2011-10-24       Impact factor: 10.121

2.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

3.  Should reducing nocturnal blood pressure be a therapeutic target in CKD? The time is ripe for a clinical outcomes trial.

Authors:  Mahboob Rahman; Lawrence J Appel
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

Review 4.  Management of blood pressure for acute and recurrent stroke.

Authors:  Venkatesh Aiyagari; Philip B Gorelick
Journal:  Stroke       Date:  2009-04-23       Impact factor: 7.914

Review 5.  Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review).

Authors:  Rod S Taylor; Kate E Ashton; Tiffany Moxham; Lee Hooper; Shah Ebrahim
Journal:  Am J Hypertens       Date:  2011-07-06       Impact factor: 2.689

6.  Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Authors:  Henry R Black; William J Elliott; Gregory Grandits; Patricia Grambsch; Tracy Lucente; William B White; James D Neaton; Richard H Grimm; Lennart Hansson; Yves Lacourciere; James Muller; Peter Sleight; Michael A Weber; Gordon Williams; Janet Wittes; Alberto Zanchetti; Robert J Anders
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

7.  Decreased slow wave sleep increases risk of developing hypertension in elderly men.

Authors:  Maple M Fung; Katherine Peters; Susan Redline; Michael G Ziegler; Sonia Ancoli-Israel; Elizabeth Barrett-Connor; Katie L Stone
Journal:  Hypertension       Date:  2011-08-29       Impact factor: 10.190

8.  Projected effect of dietary salt reductions on future cardiovascular disease.

Authors:  Kirsten Bibbins-Domingo; Glenn M Chertow; Pamela G Coxson; Andrew Moran; James M Lightwood; Mark J Pletcher; Lee Goldman
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

9.  Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.

Authors:  Roberto Minutolo; Francis B Gabbai; Silvio Borrelli; Raffaele Scigliano; Paolo Trucillo; Diego Baldanza; Simona Laurino; Sara Mascia; Giuseppe Conte; Luca De Nicola
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

10.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Authors:  Else Charlotte Sandset; Philip M W Bath; Gudrun Boysen; Dalius Jatuzis; Janika Kõrv; Stephan Lüders; Gordon D Murray; Przemyslaw S Richter; Risto O Roine; Andreas Terént; Vincent Thijs; Eivind Berge
Journal:  Lancet       Date:  2011-02-26       Impact factor: 79.321
  10 in total
  4 in total

1.  Relationship between sleep quality and the level and pattern of BP.

Authors:  Yuli Huang; Weiyi Mai; Yunzhao Hu
Journal:  Nat Rev Cardiol       Date:  2012-05-22       Impact factor: 32.419

2.  Evaluating physiological dynamics via synchrosqueezing: prediction of ventilator weaning.

Authors:  Hau-Tieng Wu; Shu-Shua Hseu; Mauo-Ying Bien; Yu Ru Kou; Ingrid Daubechies
Journal:  IEEE Trans Biomed Eng       Date:  2013-11-04       Impact factor: 4.538

3.  Qian Yang Yu Yin Granule-containing serum inhibits angiotensin II-induced proliferation, reactive oxygen species production, and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway.

Authors:  Kang Ding; Yan Wang; Weimin Jiang; Yu Zhang; Hongping Yin; Zhuyuan Fang
Journal:  BMC Complement Altern Med       Date:  2015-03-25       Impact factor: 3.659

Review 4.  Renal denervation: ultima ratio or standard in treatment-resistant hypertension.

Authors:  Alexandre Persu; Jean Renkin; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2012-07-30       Impact factor: 10.190
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.